1.
Chem Commun (Camb)
; 58(57): 7912-7915, 2022 Jul 14.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35726903
RESUMO
Pre-targeting of bispecific antibodies is probed to enhance tumour retention while limiting clearance of administered multifunctional branched PEGylated nanomedicines. The temporal influence of pre-targeting on polymer interaction with tumour cells and tissue is explored using in vitro assays through to preclinical validation.